MAPLE GROVE, Minn.--(BUSINESS WIRE)--Pursuit Vascular announced today that its ClearGuard HD Antimicrobial Barrier Caps received a Bronze Award at the 19th Annual Medical Design Excellence Awards (MDEA) competition. Winners were announced at a presentation ceremony held on Tuesday, June 14, 2016 at the Jacob K. Javits Convention Center in New York City. This award was received in the Drug-Delivery Devices and Combination Products category of the competition.
“We are honored to receive this prestigious award from a very competitive field of applicants”
The prevalence of hemodialysis catheters remains high, and despite current infection control procedures results in costly and deadly catheter-related bloodstream infections. The new ClearGuard HD Antimicrobial Barrier Cap is used by leading dialysis providers across the country and is the first and only device cleared for sale in the U.S. that kills infection-causing bacteria inside a long-term hemodialysis catheter. The patented, elegant design is simple to use yet highly effective, clinically proven to substantially reduce both bloodstream infections and hospitalizations. Feedback from nurses and technicians in outpatient dialysis clinics has been outstanding, and the intuitive design may even enable more home-based dialysis and patient self-care in the future.
“We are honored to receive this prestigious award from a very competitive field of applicants,” said Doug Killion, President and CEO of Pursuit Vascular. “It reaffirms the significant advancement in patient care our product provides. Clinical results have been submitted for publication which demonstrates the power of ClearGuard HD Antimicrobial Barrier Caps to rapidly change the standard of care for hemodialysis patients in the United States.”
About the Medical Design Excellence Awards
The MDEA is the medical technology industry’s premier design competition, and its panel of third-party jurors are committed to searching worldwide for the highest caliber medical devices that save lives, improve patient healthcare and transform medical technology. Entries are judged by an impartial panel of experts, including practicing doctors, nurses, and technicians as well as industrial designers, engineers, manufacturers, and human factors experts. The MDEA Juror Panel selects products based on design and engineering innovation; function and user-related innovation; patient benefits; business benefits; and overall benefit to the healthcare system. For more information visit mdeawards.mddionline.com
About the ClearGuard HD Antimicrobial Barrier Cap
The ClearGuard HD Antimicrobial Barrier Cap is the first and only device cleared for sale in the U.S. that kills infection-causing bacteria inside a long-term hemodialysis catheter; triggering the creation of new Product Code (PEH) by the Food and Drug Administration (FDA). This simple yet revolutionary single-use device is protected by six issued U.S. patents, and several other U.S. and International patent applications are pending. For more information visit www.clearguardhd.com
About Pursuit Vascular
Headquartered in Maple Grove, Minnesota, Pursuit Vascular, Inc. is developing a family of innovative single-use products designed to protect patients from acquiring life-threatening infections associated with long-term catheter and port use, while reducing the cost of healthcare. For more information visit www.pursuitvascular.com
Contacts
Pursuit Vascular, Inc.
Doug Killion, 612-424-9006
